PERSPECTA

News from every angle

← Back to headlines

Evogene Addresses Dissident Shareholder Concerns

Biotech company Evogene outlines its transformation strategy and commercial progress in response to activist shareholder pressure.

31 Aug, 12:23 — 31 Aug, 12:23
PostShare

Sources

Showing 1 of 1 sources
morningstar3d ago

Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward - Morningstar

Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward  Morningstar

Read full article →

Related Stories

Snowflake Reports Strong Second-Quarter Earnings Driven by AI Adoption

27m ago

Alstom Wins $4.7 Billion Contract to Build New VIA Rail Cars in Canada

52m ago

Revolut Secures Conditional US National Bank Charter Approval

52m ago

Mortgage Rates Climb to 7% in US and Set to Rise in UK

52m ago